Clinical Trial Update: Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors [EARLY_Phase 1]

View source ↗

Summary

This early-phase clinical trial update describes an imaging study evaluating the Ga-68 labeled NOTA-RF PET tracer targeting RFVT3 in patients with pituitary neo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Neoplasms

Drugs mentioned

• [68Ga]Ga-NOTA-RF (Ga-68 NOTA-RF radiopharmaceutical targeting RFVT3)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pituitary Neoplasms | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION